Preventive effects of danazol on endometrial carcinogenesis in mice
article
OA: closed
CC0
⤵ 5 in-corpus citations
AI-generated summary
This study investigated the preventive effects of danazol on endometrial carcinogenesis in mice and found it reduced tumor development.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Short and long-term experiments were designed to determine effects of danazol on estrogen-related endometrial carcinogenesis in mice. The short-term assays showed that danazol decreased expression levels of c-fos/jun mRNA and their oncoproteins induced by estradiol-17beta (E2). For the long-term assay, 85 female ICR mice were given N-methyl-N-nitrsourea solution into their uterine corpora. The animals were divided into three groups as follows: Group 1, E2-diet (5 ppm) plus danazol (2 mg/body (s.c.), every 4 weeks); Group 2, E2-diet alone, Group 3, basal diet alone. At 30 weeks, incidences of atypical and complex endometrial hyperplasia were significantly decreased by danazol-treatment. These results suggest that danazol has preventive effects on estrogen-related endometrial carcinogenesis in mice, through the suppression of estrogen-induced c-fos/jun-expression.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (22)
- Clinical effects of danazol on endometrial hyperplasia in menopausal and postmenopausal women via openalex
- Clinical Studies with an Antigonadotropin-Danazol via openalex
- Danazol: An antigonadotropic agent in the treatment of pelvic endometriosis via openalex
- Effects of an androgenic derivative on the development of chemically-induced mammary carcinogenesis in the rat. via openalex
- Endocrine changes in postmenopausal women after high-dose danazol therapy. via openalex
- Preliminary report on the use of danazol in the treatment of endometrial adenomatous hyperplasia via openalex
- The effectiveness of danazol therapy in postmenopausal women affected by endometrial hyperplasia. via openalex
- doi:10.1242/dev.99.4.449 via openalex
- W3142797338 via openalex
- W6716593565 via openalex
- W6792183410 via openalex
- doi:10.1111/j.1349-7006.1995.tb02460.x via openalex
- doi:10.1111/j.1349-7006.1993.tb00183.x via openalex
- doi:10.1016/0378-1119(90)90087-8 via openalex
- doi:10.1016/0304-3835(95)03979-7 via openalex
- doi:10.1016/0092-8674(83)90306-9 via openalex
- doi:10.1210/mend-2-9-816 via openalex
- doi:10.1210/mend-4-7-1041 via openalex
- doi:10.1007/978-3-642-85014-1 via openalex
- doi:10.1111/j.1349-7006.1998.tb03290.x via openalex
- doi:10.1111/j.1349-7006.1999.tb00807.x via openalex
- doi:10.1038/334629a0 via openalex
Cited by (5)
- Androgen Signaling in Uterine Diseases: New Insights and New Targets 2022
- MicroRNA-Regulated Pathways Associated with Endometriosis 2008
- Endometriosis: harmful survival of an ectopic tissue 2006
- FOXO1 and c-jun transcription factors mRNA are modulated in endometriosis 2004
- Phase II trial of danazol in advanced, recurrent, or persistent endometrial cancer: a Gynecologic Oncology Group study 2003
Source provenance
- openalex
- last seen: 2026-05-11T06:00:05.006021+00:00
- unpaywall
- last seen: 2026-07-27T06:55:32.580041+00:00
License: CC0
· commercial use OK